Form 20-F ☑
|
Form 40-F ☐
|
Yes ☐
|
No ☑
|
EXFO INC.
|
|
By: /s/ Benoit Ringuette
Name: Benoit Ringuette
Title: General Counsel and Corporate Secretary
|
|
§
|
Sales reach US$63.0 million, top of guidance range
|
§
|
Bookings attain US$66.3 million, book-to-bill ratio of 1.05
|
§
|
Adjusted EBITDA totals US$8.5 million, 13.6% of sales
|
§
|
Sales increase 4.6% to US$243.3 million
|
§
|
Bookings improve 4.8% to US$251.8 million
|
§
|
Adjusted EBITDA totals US$22.0 million, 9.1% of sales
|
Q4 2017
|
Q3 2017
|
Q4 2016
|
FY 2017
|
FY 2016
|
||||||||||||||||
Physical-layer sales
|
$
|
40,802
|
$
|
41,007
|
$
|
39,777
|
$
|
161,864
|
$
|
151,910
|
||||||||||
Protocol-layer sales
|
22,122
|
17,678
|
23,445
|
81,905
|
83,324
|
|||||||||||||||
Foreign exchange gains (losses) on forward exchange contracts
|
57
|
(180
|
)
|
(364
|
)
|
(468
|
)
|
(2,651
|
)
|
|||||||||||
Total Sales
|
$
|
62,981
|
$
|
58,505
|
$
|
62,858
|
$
|
243,301
|
$
|
232,583
|
||||||||||
Physical-layer bookings
|
$
|
39,322
|
$
|
47,157
|
$
|
39,826
|
$
|
165,886
|
$
|
155,320
|
||||||||||
Protocol-layer bookings
|
26,943
|
16,691
|
22,969
|
86,348
|
87,631
|
|||||||||||||||
Foreign exchange gains (losses) on forward exchange contracts
|
57
|
(180
|
)
|
(364
|
)
|
(468
|
)
|
(2,651
|
)
|
|||||||||||
Total Bookings
|
$
|
66,322
|
$
|
63,668
|
$
|
62,431
|
$
|
251,766
|
$
|
240,300
|
||||||||||
Book-to-bill ratio (Bookings/Sales)
|
1.05
|
1.09
|
0.99
|
1.03
|
1.03
|
|||||||||||||||
Gross margin before depreciation and amortization*
|
$
|
39,009
|
$
|
33,950
|
$
|
38,713
|
$
|
148,972
|
$
|
145,517
|
||||||||||
61.9
|
%
|
58.0
|
%
|
61.6
|
%
|
61.2
|
%
|
62.6
|
%
|
|||||||||||
Other selected information:
|
||||||||||||||||||||
IFRS net earnings (loss)
|
$
|
844
|
$
|
(4,304
|
)
|
$
|
2,252
|
$
|
851
|
$
|
8,900
|
|||||||||
Amortization of intangible assets
|
$
|
1,048
|
$
|
1,046
|
$
|
292
|
$
|
3,289
|
$
|
1,172
|
||||||||||
Stock-based compensation costs
|
$
|
431
|
$
|
372
|
$
|
302
|
$
|
1,414
|
$
|
1,378
|
||||||||||
Restructuring charges
|
$
|
1,266
|
$
|
3,813
|
$
|
−
|
$
|
5,079
|
$
|
−
|
||||||||||
Change in fair value of cash contingent consideration
|
$
|
(383
|
)
|
$
|
−
|
$
|
−
|
$
|
(383
|
)
|
$
|
−
|
||||||||
Net income tax effect of the above items
|
$
|
(275
|
)
|
$
|
(357
|
)
|
$
|
(31
|
)
|
$
|
(858
|
)
|
$
|
(120
|
)
|
|||||
Foreign exchange (gain) loss
|
$
|
2,943
|
$
|
(1,725
|
)
|
$
|
293
|
$
|
978
|
$
|
(161
|
)
|
||||||||
Adjusted EBITDA*
|
$
|
8,545
|
$
|
2,300
|
$
|
6,172
|
$
|
22,041
|
$
|
22,039
|
§
|
Sales. Total sales increased 4.6% to US$243.3 million in fiscal 2017 mainly due to EXFO's leadership in optical testing, ongoing 100G investment cycle among communications service providers and the company's growing business with web-scale operators. Sales of Physical-layer solutions (optical and copper access) increased 6.6% year-over-year, while sales of Protocol-layer solutions (transport, datacom, service assurance, analytics and wireless products) dipped 1.7%.
|
§
|
Profitability. EXFO generated adjusted EBITDA of US$22.0 million, or 9.1% of sales, in fiscal 2017 compared to US$22.0 million, or 9.5% of sales, in 2016. The company also delivered US$12.9 million in cash flows from operating activities in 2017 compared to US$24.4 million in 2016.
|
·
|
Innovation. EXFO launched 16 new products and/or major enhancements in fiscal 2017, addressing four key technology areas: fiber, Cloud, network virtualization and 5G. New product introductions included a 400 Gbit/s optical transport test solution for the lab and manufacturing markets; an automated inspection probe for testing multi-fiber connectors in data centers and radio access networks; a software-based solution, Universal Virtual Synch, enabling communications service providers to accurately and cost-effectively measure network latency; and optical RF over OBSAI (open base station architecture initiative) link test capabilities to complement optical RF over CPRI (common public radio interface) test technology for centralized radio access networks.
|
Q4 2017
|
Q3 2017
|
Q4 2016
|
FY 2017
|
FY 2016
|
||||||||||||||||
IFRS net earnings (loss) for the period
|
$
|
844
|
$
|
(4,304
|
)
|
$
|
2,252
|
$
|
851
|
$
|
8,900
|
|||||||||
Add (deduct):
|
||||||||||||||||||||
Depreciation of property, plant and equipment
|
1,008
|
1,029
|
957
|
3,902
|
3,814
|
|||||||||||||||
Amortization of intangible assets
|
1,048
|
1,046
|
292
|
3,289
|
1,172
|
|||||||||||||||
Interest and other (income) expenses
|
275
|
57
|
(112
|
)
|
303
|
(828
|
)
|
|||||||||||||
Income taxes
|
1,113
|
2,012
|
2,188
|
6,608
|
7,764
|
|||||||||||||||
Stock-based compensation costs
|
431
|
372
|
302
|
1,414
|
1,378
|
|||||||||||||||
Restructuring charges
|
1,266
|
3,813
|
–
|
5,079
|
–
|
|||||||||||||||
Change in fair value of cash
contingent consideration
|
(383
|
)
|
–
|
–
|
(383
|
)
|
–
|
|||||||||||||
Foreign exchange (gain) loss
|
2,943
|
(1,725
|
)
|
293
|
978
|
(161
|
)
|
|||||||||||||
Adjusted EBITDA for the period
|
$
|
8,545
|
$
|
2,300
|
$
|
6,172
|
$
|
22,041
|
$
|
22,039
|
||||||||||
Adjusted EBITDA in percentage of sales
|
13.6
|
%
|
3.9
|
%
|
9.8
|
%
|
9.1
|
%
|
9.5
|
%
|
As at August 31,
|
||||||||
2017
|
2016
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash
|
$
|
38,435
|
$
|
43,208
|
||||
Short-term investments
|
775
|
4,087
|
||||||
Accounts receivable
|
||||||||
Trade
|
41,130
|
42,993
|
||||||
Other
|
3,907
|
2,474
|
||||||
Income taxes and tax credits recoverable
|
4,955
|
4,208
|
||||||
Inventories
|
33,832
|
33,004
|
||||||
Prepaid expenses
|
4,202
|
3,099
|
||||||
127,236
|
133,073
|
|||||||
Tax credits recoverable
|
38,111
|
34,594
|
||||||
Property, plant and equipment
|
40,132
|
35,978
|
||||||
Intangible assets
|
11,183
|
3,391
|
||||||
Goodwill
|
35,077
|
21,928
|
||||||
Deferred income tax assets
|
6,555
|
8,240
|
||||||
Other assets
|
947
|
589
|
||||||
$
|
259,241
|
$
|
237,793
|
|||||
Liabilities
|
||||||||
Current liabilities
|
||||||||
Accounts payable and accrued liabilities
|
$
|
36,776
|
$
|
37,174
|
||||
Provisions
|
3,889
|
299
|
||||||
Income taxes payable
|
663
|
971
|
||||||
Deferred revenue
|
11,554
|
9,486
|
||||||
52,882
|
47,930
|
|||||||
Deferred revenue
|
6,257
|
5,530
|
||||||
Deferred income tax liabilities
|
3,116
|
2,857
|
||||||
Other liabilities
|
196
|
75
|
||||||
62,451
|
56,392
|
|||||||
Shareholders' equity
|
||||||||
Share capital
|
90,411
|
85,516
|
||||||
Contributed surplus
|
18,184
|
18,150
|
||||||
Retained earnings
|
127,160
|
126,309
|
||||||
Accumulated other comprehensive loss
|
(38,965
|
)
|
(48,574
|
)
|
||||
196,790
|
181,401
|
|||||||
$
|
259,241
|
$
|
237,793
|
Three months
ended
August 31, 2017
|
Twelve months
ended
August 31, 2017
|
Three months
ended
August 31, 2016
|
Twelve months
ended
August 31, 2016
|
|||||||||||||
Sales
|
$
|
62,981
|
$
|
243,301
|
$
|
62,858
|
$
|
232,583
|
||||||||
Cost of sales (1,2)
|
23,972
|
94,329
|
24,145
|
87,066
|
||||||||||||
Selling and administrative (2)
|
20,834
|
86,256
|
21,554
|
82,169
|
||||||||||||
Net research and development (2)
|
11,327
|
47,168
|
11,289
|
42,687
|
||||||||||||
Depreciation of property, plant and equipment
|
1,008
|
3,902
|
957
|
3,814
|
||||||||||||
Amortization of intangible assets
|
1,048
|
3,289
|
292
|
1,172
|
||||||||||||
Change in fair value of cash contingent consideration
|
(383
|
)
|
(383
|
)
|
‒
|
‒
|
||||||||||
Interest and other (income) expense
|
275
|
303
|
(112
|
)
|
(828
|
)
|
||||||||||
Foreign exchange (gain) loss
|
2,943
|
978
|
293
|
(161
|
)
|
|||||||||||
Earnings before income taxes
|
1,957
|
7,459
|
4,440
|
16,664
|
||||||||||||
Income taxes
|
1,113
|
6,608
|
2,188
|
7,764
|
||||||||||||
Net earnings for the period
|
$
|
844
|
$
|
851
|
$
|
2,252
|
$
|
8,900
|
||||||||
Basic net earnings per share
|
$
|
0.02
|
$
|
0.02
|
$
|
0.04
|
$
|
0.17
|
||||||||
Diluted net earnings per share
|
$
|
0.02
|
$
|
0.02
|
$
|
0.04
|
$
|
0.16
|
||||||||
Basic weighted average number of shares outstanding (000's)
|
54,708
|
54,423
|
53,769
|
53,863
|
||||||||||||
Diluted weighted average number of shares outstanding (000's)
|
55,784
|
55,555
|
54,709
|
54,669
|
(1)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(2)
|
Restructuring charges included in:
|
Cost of sales
|
$ |
115
|
$ |
1,697
|
$ |
‒
|
$ |
‒
|
||||||||
Selling and administrative | 231 | 1,150 | ‒ | ‒ | ||||||||||||
Net research and development
|
920
|
2,232
|
‒
|
‒
|
||||||||||||
|
$
|
1,266
|
$
|
5,079
|
$
|
‒
|
$
|
‒
|
Three months
ended
August 31, 2017
|
Twelve months
ended
August 31, 2017
|
Three months
ended
August 31, 2016
|
Twelve months
ended
August 31, 2016
|
|||||||||||||
Net earnings for the period
|
$
|
844
|
$
|
851
|
$
|
2,252
|
$
|
8,900
|
||||||||
Other comprehensive income (loss), net of income taxes
|
||||||||||||||||
Items that will not be reclassified subsequently to net earnings
|
||||||||||||||||
Foreign currency translation adjustment
|
13,028
|
8,262
|
(68
|
)
|
707
|
|||||||||||
Items that may be reclassified subsequently to net earnings
|
||||||||||||||||
Unrealized gains/losses on forward exchange contracts
|
1,765
|
1,403
|
37
|
862
|
||||||||||||
Reclassification of realized gains/losses on forward exchange contracts in net earnings
|
64
|
423
|
414
|
2,797
|
||||||||||||
Deferred income tax effect of gains/losses on forward exchange contracts
|
(510
|
)
|
(479
|
)
|
(111
|
)
|
(935
|
)
|
||||||||
Other comprehensive income
|
14,347
|
9,609
|
272
|
3,431
|
||||||||||||
Comprehensive income for the period
|
$
|
15,191
|
$
|
10,460
|
$
|
2,524
|
$
|
12,331
|
Year ended August 31, 2016
|
||||||||||||||||||||
Share
capital |
Contributed
surplus |
Retained
earnings |
Accumulated
other comprehensive loss |
Total
shareholders' equity |
||||||||||||||||
Balance as at September 1, 2015
|
$
|
86,045
|
$
|
17,778
|
$
|
117,409
|
$
|
(52,005
|
)
|
$
|
169,227
|
|||||||||
Redemption of share capital
|
(1,768
|
)
|
217
|
–
|
–
|
(1,551
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs
|
1,239
|
(1,239
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,394
|
–
|
–
|
1,394
|
|||||||||||||||
Net earnings for the year
|
–
|
–
|
8,900
|
–
|
8,900
|
|||||||||||||||
Other comprehensive income
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
707
|
707
|
|||||||||||||||
Changes in unrealized gains/losses on forward exchange contracts, net of deferred income taxes of $935
|
–
|
–
|
–
|
2,724
|
2,724
|
|||||||||||||||
Total comprehensive income for the year
|
12,331
|
|||||||||||||||||||
Balance as at August 31, 2016
|
$
|
85,516
|
$
|
18,150
|
$
|
126,309
|
$
|
(48,574
|
)
|
$
|
181,401
|
Year ended August 31, 2017
|
||||||||||||||||||||
Share
capital |
Contributed
surplus |
Retained
earnings |
Accumulated
other comprehensive loss |
Total
shareholders' equity |
||||||||||||||||
Balance as at September 1, 2016
|
$
|
85,516
|
$
|
18,150
|
$
|
126,309
|
$
|
(48,574
|
)
|
$
|
181,401
|
|||||||||
Issuance of share capital
|
3,490
|
–
|
–
|
–
|
3,490
|
|||||||||||||||
Reclassification of stock-based compensation costs
|
1,405
|
(1,405
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,439
|
–
|
–
|
1,439
|
|||||||||||||||
Net earnings for the year
|
–
|
–
|
851
|
–
|
851
|
|||||||||||||||
Other comprehensive income
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
8,262
|
8,262
|
|||||||||||||||
Changes in unrealized gains/losses on forward exchange contracts, net of deferred income taxes of $479
|
–
|
–
|
–
|
1,347
|
1,347
|
|||||||||||||||
Total comprehensive income for the year
|
10,460
|
|||||||||||||||||||
Balance as at August 31, 2017
|
$
|
90,411
|
$
|
18,184
|
$
|
127,160
|
$
|
(38,965
|
)
|
$
|
196,790
|
Three months
ended
August 31, 2017
|
Twelve months
ended
August 31, 2017
|
Three months
ended
August 31, 2016
|
Twelve months
ended
August 31, 2016
|
|||||||||||||
Cash flows from operating activities
|
||||||||||||||||
Net earnings for the period
|
$
|
844
|
$
|
851
|
$
|
2,252
|
$
|
8,900
|
||||||||
Add (deduct) items not affecting cash
|
||||||||||||||||
Stock-based compensation costs
|
494
|
1,477
|
302
|
1,378
|
||||||||||||
Depreciation and amortization
|
2,056
|
7,191
|
1,249
|
4,986
|
||||||||||||
Change in fair value of cash contingent consideration
|
(383
|
)
|
(383
|
)
|
‒
|
‒
|
||||||||||
Deferred revenue
|
(1,303
|
)
|
1,723
|
(638
|
)
|
4,238
|
||||||||||
Deferred income taxes
|
(109
|
)
|
1,054
|
293
|
1,578
|
|||||||||||
Changes in foreign exchange gain/loss
|
2,051
|
1,096
|
1
|
(332
|
)
|
|||||||||||
3,650
|
13,009
|
3,459
|
20,748
|
|||||||||||||
Changes in non-cash operating items
|
||||||||||||||||
Accounts receivable
|
2,254
|
3,955
|
(712
|
)
|
2,682
|
|||||||||||
Income taxes and tax credits
|
(1,154
|
)
|
(2,386
|
)
|
307
|
939
|
||||||||||
Inventories
|
920
|
911
|
1,914
|
(4,713
|
)
|
|||||||||||
Prepaid expenses
|
(157
|
)
|
(918
|
)
|
138
|
(280
|
)
|
|||||||||
Other assets
|
6
|
(121
|
)
|
(33
|
)
|
170
|
||||||||||
Accounts payable, accrued liabilities and provisions
|
(3,501
|
)
|
(1,745
|
)
|
(1,524
|
)
|
4,882
|
|||||||||
Other liabilities
|
165
|
165
|
(6
|
)
|
(65
|
)
|
||||||||||
2,183
|
12,870
|
3,543
|
24,363
|
|||||||||||||
Cash flows from investing activities
|
||||||||||||||||
Additions to short-term investments
|
(23
|
)
|
(2,910
|
)
|
(416
|
)
|
(3,546
|
)
|
||||||||
Proceeds from disposal and maturity of short-term investments
|
2,778
|
6,374
|
372
|
873
|
||||||||||||
Purchases of capital assets
|
(1,727
|
)
|
(7,175
|
)
|
(982
|
)
|
(4,356
|
)
|
||||||||
Business combinations, net of cash acquired
|
(313
|
)
|
(12,792
|
)
|
‒
|
‒
|
||||||||||
715
|
(16,503
|
)
|
(1,026
|
)
|
(7,029
|
)
|
||||||||||
Cash flows from financing activities
|
||||||||||||||||
Bank loan
|
‒
|
‒
|
(468
|
)
|
‒
|
|||||||||||
Repayment of long-term debt
|
‒
|
(1,480
|
)
|
‒
|
‒
|
|||||||||||
Redemption of share capital
|
‒
|
‒
|
(1,149
|
)
|
(1,551
|
)
|
||||||||||
‒
|
(1,480
|
)
|
(1,617
|
)
|
(1,551
|
)
|
||||||||||
Effect of foreign exchange rate changes on cash
|
1,164
|
340
|
35
|
1,561
|
||||||||||||
Change in cash
|
4,062
|
(4,773
|
)
|
935
|
17,344
|
|||||||||||
Cash – Beginning of the period
|
34,373
|
43,208
|
42,273
|
25,864
|
||||||||||||
Cash – End of the period
|
$
|
38,435
|
$
|
38,435
|
$
|
43,208
|
$
|
43,208
|